Latest Breaking News On - Single dose portion - Page 1 : comparemela.com

Protagenic Therapeutics Stress-Regulating Peptide Demonstrates Exceptional

Protagenic Therapeutics Stress-Regulating Peptide Demonstrates Exceptional
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesRobertb steinProtagenic therapeutics incNews networkAdvisory incCompany contactClinically relevant adverse events reportedSingle dose portionMultiple dose portionCall scheduledDiscuss potential impactProtagenic therapeuticsChief medicalAccess codeLooking statements

Protagenic Therapeutics, Inc : Protagenic Therapeutics Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial, Paving the Way for Next Steps Toward Potential Breakthrough Treatments in Stress Related Neuropsychi

No Clinically-Relevant Adverse Events Reported in Single Dose Portion, Multiple Dose Portion to CommenceInvestor Call Scheduled for today, Wednesday, May 22, at 10:00 am ET to Discuss Potential Impact

New yorkUnited statesRobertb steinCompany contactAdvisory incProtagenic therapeutics incSingle dose portionMultiple dose portionCall scheduledDiscuss potential impactProtagenic therapeuticsChief medicalAccess codeLooking statementsChief financial officerRelations contact

Protagenic Therapeutics Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial, Paving the Way for Next Steps Toward Potential Breakthrough Treatments in Stress Related Neuropsychiatric Disorders

No Clinically-Relevant Adverse Events Reported in Single Dose Portion, Multiple Dose Portion to Commence Investor Call Scheduled for today, Wednesday, May 22, at 10:00 am ET to Discuss Potential Impact on PTSD, Depression, Anxiety, Addiction, and Obesity NEW YORK, NY / ACCESSWIRE / May 22, 2024 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX), a leader in biopharmaceutical innovation, today announced the complete safety data set from

Single dose portionMultiple dose portionInvestor call scheduledDiscuss potential impact

Protagenic Therapeutics (PTIX) Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial

Protagenic Therapeutics (PTIX) Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Robertb steinProtagenic therapeutics incSingle dose portionMultiple dose portionCall scheduledDiscuss potential impactChief medical